Gaithersburg, MD, United States of America

Haodong Li

USPTO Granted Patents = 60 

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 458(Granted Patents)


Inventors with similar research interests:


Location History:

  • Gaitheresburg, MD (US) (2000 - 2003)
  • Germantown, MD (US) (1996 - 2004)
  • Gaithersburg, MD (US) (1997 - 2010)

Company Filing History:


Years Active: 1996-2010

Loading Chart...
Areas of Expertise:
Myeloid Progenitor Inhibitory Factor-1
Chemokine Alpha-3
Leukocyte Adhesion Inhibitor-1
Natural Killer Cell Activating Factor II
Macrophage Inflammatory Protein-4
Human Chemokine Beta-10
Extracellular Growth Factor
Antibodies to Chemokines
Polynucleotides Encoding Proteins
Stem Cell Mobilization
Cytokine Polypeptides
Growth Factor HTTER36
60 patents (USPTO):Explore Patents

Title: The Innovations of Haodong Li: A Pioneer in Chemokine Therapeutics

Introduction: Haodong Li, based in Gaithersburg, MD, has established himself as a significant figure in the field of biomedical innovations, holding an impressive total of 60 patents. His work primarily focuses on chemokine polypeptides and their therapeutic applications, which are groundbreaking in the treatment of various diseases.

Latest Patents: Among his recent innovations, Haodong Li has developed therapeutic compositions and methods involving isolated nucleic acid molecules encoding human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides. These compositions demonstrate potential in treating a range of conditions including leukemia, tumors, and chronic infections. Additionally, he has disclosed methods for generating human chemokine Alpha-3 polypeptides and procedures for their therapeutic use, along with methods to diagnose related diseases through innovative assays.

Career Highlights: Haodong Li’s extensive career includes notable contributions while working at Human Genome Sciences, Inc. His research has led to advancements in understanding and manipulating chemokines for therapeutic purposes, thus making him a key player in the domain of biomedical research and applied innovations.

Collaborations: Throughout his career, Haodong has collaborated with experts including Mark D. Adams and Steven M. Ruben. These partnerships have likely enriched his work and propelled his research initiatives, leveraging different perspectives and expertise within the field.

Conclusion: With 60 patents to his name, Haodong Li continues to be a driving force in innovations surrounding chemokine therapeutics and diagnostics. His significant contributions provide promising prospects for advancements in treating complex diseases, thereby enhancing healthcare solutions. His work is a testament to the power of innovation in improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…